Cargando…

Granulocyte and monocyte adsorptive apheresis ameliorates sepsis in rats

BACKGROUND: Overwhelming activation of granulocytes and monocytes is central to inflammatory responses during sepsis. Granulocyte and monocyte adsorptive apheresis (GMA) is an extracorporeal leukocyte apheresis device filled with cellulose acetate beads and selectively adsorbs granulocytes and monoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Shuai, Xu, Qingqing, Deng, Bo, Zheng, Yin, Tian, Hongyan, Wang, Li, Ding, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366986/ https://www.ncbi.nlm.nih.gov/pubmed/28342161 http://dx.doi.org/10.1186/s40635-017-0129-2

Ejemplares similares

Use of granulocyte and monocyte adsorption apheresis in dermatology (Review)
por: Gnesotto, Laura, et al.
Publicado: (2022)

Sweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis
por: Fujii, Asami, et al.
Publicado: (2017)

Combined effects of granulocyte and monocyte adsorption apheresis and corticosteroids on ulcerative colitis
por: Tsuzuki, Yoshikazu, et al.
Publicado: (2023)

Is Adsorptive Granulocyte and Monocyte Apheresis Effective as an Alternative Treatment Option in Patients with Ulcerative Colitis?
por: Jeon, Seong Ran
Publicado: (2017)

Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China
por: Lai, Ya-Min, et al.
Publicado: (2017)

Efficacy and Safety of Adsorptive Granulocyte and Monocyte Apheresis in Elderly and Pregnant Patients With Ulcerative Colitis
por: Yanagisawa, Kazuki, et al.
Publicado: (2019)

Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19
por: Kanekura, Takuro, et al.
Publicado: (2020)

Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis
por: Nakamura, Masanao, et al.
Publicado: (2020)

Peripheral Blood CD64 Levels Decrease in Crohn's Disease following Granulocyte and Monocyte Adsorptive Apheresis
por: Chiba, Toshimi, et al.
Publicado: (2011)

Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2015)

Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2021)

Combination Therapy With Tofacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction Therapy for Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2020)

Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA
por: Yokoyama, Yoko, et al.
Publicado: (2013)

Successful Use of Granulocyte and Monocyte Adsorptive Apheresis in a Patient with Post-COVID-19 Multisystem Inflammatory Syndrome in Adults
por: Kaneko, Shuzo, et al.
Publicado: (2023)

Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn's Disease
por: Ozeki, Keiji, et al.
Publicado: (2012)

Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study
por: Motoya, Satoshi, et al.
Publicado: (2019)

Granulocyte and Monocyte Adsorptive Apheresis for Ulcerative Colitis in a Patient with Low Bone Mineral Density Due to Fanconi-Bickel Syndrome
por: Tanaka, Makoto, et al.
Publicado: (2021)

Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future
por: Chen, Xiu-Li, et al.
Publicado: (2020)

Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports
por: Martínez, Ana Victoria Carro, et al.
Publicado: (2021)

Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn’s disease
por: Fukuchi, Takumi, et al.
Publicado: (2014)

Adsorptive Granulocyte/Monocyte Apheresis for the Maintenance of Remission in Patients with Ulcerative Colitis: A Prospective Randomized, Double Blind, Sham-Controlled Clinical Trial
por: Fukunaga, Ken, et al.
Publicado: (2012)

Infliximab- and Immunosuppressant-Resistant Crohn's Disease Successfully Treated with Adsorptive Granulocyte Apheresis Combined with Prednisolone
por: Itagaki, Munenori, et al.
Publicado: (2012)

Granulocyte and monocyte/macrophage apheresis in paediatric patients with ulcerative colitis: a case series in Spain
por: de Carpi, Javier Martin
Publicado: (2022)

Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study
por: Ueno, Nobuhiro, et al.
Publicado: (2021)

Intensive Frequent Granulocyte Adsorptive Apheresis Therapy for Acute Fulminant Ulcerative Colitis: Two Consecutive Case Reports
por: Furuto, Yoshitaka, et al.
Publicado: (2023)

Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial
por: Kakimoto, Kazuki, et al.
Publicado: (2020)

Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report
por: Koroku, Miki, et al.
Publicado: (2022)

Induction Therapy With a Combination of Weekly Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Ulcerative Colitis and Failure of Conventional Agents, Biologics and Janus Kinase Inhibitor
por: Tanida, Satoshi, et al.
Publicado: (2023)

Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases – a case report and literature review
por: Mastronardi, Mauro, et al.
Publicado: (2023)

Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease
por: Lindberg, Annelie, et al.
Publicado: (2010)

An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn’s disease
por: Yoshimura, Naoki, et al.
Publicado: (2015)

Granulocyte-Monocyte Apheresis in Steroid-Dependent, Azathioprine-Intolerant/Resistant Moderate Ulcerative Colitis: A Prospective Multicenter Study
por: Imperiali, Gianni, et al.
Publicado: (2017)

Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre study
por: Yamamoto, Takayuki, et al.
Publicado: (2016)

Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta-analysis
por: Kiss, Szabolcs, et al.
Publicado: (2021)

Granulocyte Apheresis: Can It Be Associated with Anti PD-1 Therapy for Melanoma?
por: Sernicola, Alvise, et al.
Publicado: (2022)

A Case of Old Age-Onset Generalized Pustular Psoriasis with a Deficiency of IL-36RN (DITRA) Treated by Granulocyte and Monocyte Apheresis
por: Tominaga, Chiharu, et al.
Publicado: (2015)

Induction of mucosal healing by intensive granulocyte/monocyte adsorptive apheresis (GMA) without use of corticosteroids in patients with ulcerative colitis: long-term remission maintenance after induction by GMA and efficacy of GMA re-treatment upon relapse
por: Fukuchi, Takumi, et al.
Publicado: (2022)

Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis
por: Furebring, Mia, et al.
Publicado: (2002)

Endothelial bioreactor system ameliorates multiple organ dysfunction in septic rats
por: Ma, Shuai, et al.
Publicado: (2016)

Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results
por: Dignass, Axel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m3kj7l8900ad9ihqlg07n1room